LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Search

Henry Schein Inc

Closed

SectorHealthcare

72.75 0.22

Overview

Share price change

24h

Current

Min

71.39

Max

73.28

Key metrics

By Trading Economics

Income

11M

112M

Sales

-69M

3.4B

P/E

Sector Avg

20.843

51.415

EPS

1.32

Profit margin

3.325

Employees

25,000

EBITDA

-7M

249M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+20.41% upside

Dividends

By Dow Jones

Next Earnings

4 sie 2026

Market Stats

By TradingEconomics

Market Cap

-405M

7.9B

Previous open

72.53

Previous close

72.75

News Sentiment

By Acuity

40%

60%

127 / 345 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Henry Schein Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 maj 2025, 20:11 UTC

Acquisitions, Mergers, Takeovers

Henry Schein: William K. Daniel Joins Board

16 maj 2025, 20:10 UTC

Acquisitions, Mergers, Takeovers

Henry Schein: Strategic Investment by KKR Completed

Peer Comparison

Price change

Henry Schein Inc Forecast

Price Target

By TipRanks

20.41% upside

12 Months Forecast

Average 87.43 USD  20.41%

High 100 USD

Low 64 USD

Based on 16 Wall Street analysts offering 12 month price targets forHenry Schein Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

16 ratings

8

Buy

7

Hold

1

Sell

Technical Score

By Trading Central

66.23 / N/ASupport & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

127 / 345 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Henry Schein Inc

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
help-icon Live chat